XML 129 R110.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial instruments by category (Details 2) - ARS ($)
$ in Millions
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Statement [Line Items]      
Interest income $ 463 $ 591 $ 491
Interest expense (8,171) (10,511) (14,114)
Interest expense on lease liabilities (120) (158) (133)
Foreign exchange gains, net 14,406 11,512 (15,386)
Dividend income 0 1 34
Gain/Loss from repurchase of negotiable obligations 1,460 (156) 228
Fair value gain on financial assets at fair value through profit or loss 1,454 8,720 828
Interest and discount generated by operating credits 128 157 417
Gain on derivative financial instruments, net 33 (740) (901)
Other finance costs (463) (1,420) (923)
Total financial instruments 9,190 7,996 (29,459)
Financial Assets And Liabilities At Amortised Cost Category [Member]      
Statement [Line Items]      
Interest income 463 591 491
Interest expense (8,171) (10,511) (14,114)
Interest expense on lease liabilities (120) (158) (133)
Foreign exchange gains, net 14,406 11,512 (15,386)
Dividend income   1 34
Gain/Loss from repurchase of negotiable obligations 1,460 (156) 228
Fair value gain on financial assets at fair value through profit or loss 0 0 0
Interest and discount generated by operating credits 128 157 417
Gain on derivative financial instruments, net 0 0 0
Other finance costs (463) (1,420) (923)
Total financial instruments 7,703 16 (29,386)
Financial Assets And Liabilities At Fair Value Through Profit Or Loss Category [Member]      
Statement [Line Items]      
Interest income 0 0 0
Interest expense 0 0 0
Interest expense on lease liabilities   0 0
Foreign exchange gains, net 0 0 0
Dividend income 0 0 0
Gain/Loss from repurchase of negotiable obligations   0 0
Fair value gain on financial assets at fair value through profit or loss 1,454 8,720 828
Interest and discount generated by operating credits 0 0 0
Gain on derivative financial instruments, net 33 (740) (901)
Other finance costs 0 0 0
Total financial instruments $ 1,487 $ 7,980 $ (73)